GSK ' s Blood Cancer Drug Meets Main Goal in Late-stage Trial; Analysts Tout Comeback GSK ' s Blood Cancer Drug Meets Main Goal in Late-stage Trial; Analysts Tout Comeback

GSK said on Thursday a study showed its experimental drug Blenrep helped extend survival in patients with a type of blood cancer without symptoms worsening, marking a...Reuters Health Information
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news